Interview with AmyriAD CEO Sharon L. Rogers

Not content with co-founding a major restaurant chain, leading the development of Aricept (the standard of care for Alzheimer's Disease), running marathons and judging Olympic figure skating, Sharon L. Rogers, PhD is leading the development of a new treatment for Alzheimer's.

AmyriAD, where Sharon is CEO is in late stage trials for a drug that is designed to improve global function and cognition when used in combination with donepezil (Aricept).

Health Business Group is a boutique healthcare consulting firm that develops growth strategies for companies like AmyriAD. Contact us to learn more.